Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 5.06
-0.09 (-1.75%)
Jul 31, 2026, 4:08 PM HKT
Ocumension Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Ocumension Therapeutics stock has a consensus rating of "Buy" and an average price target of $9.57. The average 1-year stock price forecast is 89.13% higher than the current stock price, while the lowest is $8.82 (+74.31%) and the highest is $10.33 (+104.15%).
Price Target: $9.57 (+89.13%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 3, 2026.
Analyst Ratings
The average analyst rating for Ocumension Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.16 | Buy | Maintains | $10.16 | +100.79% | Apr 3, 2026 |
Financial Forecast
Revenue This Year
1.10B
from 804.35M
Increased by 37.32%
Revenue Next Year
1.42B
from 1.10B
Increased by 28.97%
EPS This Year
0.07
from -0.11
EPS Next Year
0.25
from 0.07
Increased by 257.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.